Publications

Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties.

Authors: AA Serandour, GD Brown, JD Cohen, JS Carroll

E-pub date: 27 Dec 2013

Journal name: Genome Biol

Targeting RNA-protein interactions within the human immunodeficiency virus type 1 lifecycle.

Authors: NM Bell, A L'Hernault, P Murat, JE Richards, AML Lever, S Balasubramanian

E-pub date: 23 Dec 2013

Journal name: Biochemistry

Hedgehog signaling controls T cell killing at the immunological synapse.

Authors: M de la Roche, AT Ritter, KL Angus, C Dinsmore, CH Earnshaw, JF Reiter, GM ...

E-pub date: 6 Dec 2013

Journal name: Science

Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.

Authors: C-F Lai, KD Flach, X Alexi, SP Fox, S Ottaviani, PTR Thiruchelvam, FJ Kyle,...

E-pub date: 1 Dec 2013

Journal name: Nucleic Acids Res

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

Authors: J Fangusaro, S Gururangan, TY Poussaint, RE McLendon, A Onar-Thomas, KE War...

E-pub date: 1 Dec 2013

Journal name: Cancer

Hyperpolarized singlet lifetimes of pyruvate in human blood and in the mouse.

Authors: I Marco-Rius, MCD Tayler, MI Kettunen, TJ Larkin, KN Timm, EM Serrao, TB Ro...

E-pub date: 1 Dec 2013

Journal name: NMR in Biomedicine

Defining stem cell dynamics in models of intestinal tumor initiation.

Authors: L Vermeulen, E Morrissey, M van der Heijden, AM Nicholson, A Sottoriva, S B...

E-pub date: 22 Nov 2013

Journal name: Science

Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.

Authors: A Gajjar, CF Stewart, DW Ellison, S Kaste, LE Kun, RJ Packer, S Goldman, M ...

E-pub date: 15 Nov 2013

Journal name: Clin Cancer Res

Filters

Research Groups

Core Facilities

Start date

End date

Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties.

Targeting RNA-protein interactions within the human immunodeficiency virus type 1 lifecycle.

Hedgehog signaling controls T cell killing at the immunological synapse.

Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

Hyperpolarized singlet lifetimes of pyruvate in human blood and in the mouse.

Defining stem cell dynamics in models of intestinal tumor initiation.

Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties.

Targeting RNA-protein interactions within the human immunodeficiency virus type 1 lifecycle.

Hedgehog signaling controls T cell killing at the immunological synapse.

Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

Hyperpolarized singlet lifetimes of pyruvate in human blood and in the mouse.

Defining stem cell dynamics in models of intestinal tumor initiation.

Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.